Apoptosis in a Fas-resistant, T-cell receptor-sensitive human leukaemic T-cell clone

Immunology. 1997 Mar;90(3):383-7. doi: 10.1111/j.1365-2567.1997.00383.x.

Abstract

The Fas (CD95) antigen plays a key role in regulating T-cell activation and survival. We have generated a Fas-resistant subclone of the human T-cell leukaemia line, H9, which is still able to undergo apoptosis in response to T-cell receptor ligation. Molecular analyses revealed that resistance to Fas-mediated apoptosis was due to a heterozygous mutation in the death domain of the Fas gene which generates a stop codon, and thus encodes a truncated Fas molecule. Fas ligation was able to induce apoptosis in the presence of cycloheximide, indicating that the mutant Fas molecule retained some signalling capability, which is death-domain independent. These cells will provide a useful tool for dissecting the complexities of Fas signalling pathways.

MeSH terms

  • Amino Acid Sequence
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Apoptosis / immunology*
  • Cycloheximide / pharmacology
  • Humans
  • Leukemia, T-Cell / immunology*
  • Molecular Sequence Data
  • Mutation
  • Neoplastic Stem Cells / immunology
  • Receptors, Antigen, T-Cell / immunology*
  • Tacrolimus / pharmacology
  • Tumor Cells, Cultured
  • fas Receptor / genetics
  • fas Receptor / immunology*

Substances

  • Receptors, Antigen, T-Cell
  • fas Receptor
  • Cycloheximide
  • Tacrolimus